# 119-hr-9102: BINSA Act

119-hr-9102, BINSA Act, is a 119th Congress bill sponsored by Rep. Moolenaar, John R. [R-MI-2] (R-MI); status introduced; PRIA reads it as touching household money (as of 2026-10-04).

- Canonical: https://policyrisk.com/legislation/119-hr-9102
- As of: 2026-10-04
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-9102
- Congress: 119
- Title: BINSA Act
- Status: introduced
- Introduced: 2026-06-02
- Sponsor: Rep. Moolenaar, John R. [R-MI-2] (R-MI)
- Cosponsors: 1
- Policy area: Science, Technology, Communications
- Touches household money: yes
- Last recorded action: 2026-10-04

## Summary

**This bill would expand the Defense Production Act to treat certain biotechnology transfers as national-security sensitive, with a focus on pharmaceutical and biologics licensing, know-how, and manufacturing.** It would push agencies to write rules and report on U.S. capital flowing to biotech sectors tied to the People’s Republic of China. - U.S. biotechnology companies and researchers would face tighter screening for licensing, joint ventures, and equity investments that involve drug discovery platforms, clinical development capabilities, or biologics manufacturing. These activities could be placed in prohibited or notifiable technology categories. - Investors and dealmakers would see higher scrutiny for cross-border transactions that transfer pharmaceutical innovation capacity or manufacturing know-how to entities subject to PRC direction or control. Treasury rulemaking would single out IP licensing and platform transfers as priority areas. - Federal agencies and Congress would get new steps to act on this risk. Treasury must issue a defining rule within 1 year with HHS, Defense, and intelligence consultation. Defense must deliver an unclassified report, with a possible classified annex, to specified congressional committees within 60 days.

## Cosponsors (1)

- Rep. Dingell, Debbie [D-MI-6] (D-MI), 2026-06-02T00:00:00.000Z

## Provisions PRIA read

- New biotech screening for investors: mixed, medium. This bill would expand the Defense Production Act to cover research, development, manufacturing, and commercialization of drugs, biologics, and therapeutic compounds. It would add licensing a prohibited technology from a covered foreign person to the list of activities the Act can screen and contro…

## Related bills

- 119-hr-3151: SHIPS for America Act of 2025
- 119-hr-9237: Take Care of America’s Veterans Act
- 119-hr-2725: Affordable Housing Credit Improvement Act of 2025
- 119-hr-3654: TERRA Act
- 119-hr-137: TCJA Permanency Act
- 119-hr-6766: Essential Caregivers Act of 2025

## Sources
- [119-hr-9102 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/9102)

## Related
- [119-hr-3151: SHIPS for America Act of 2025](https://policyrisk.com/legislation/119-hr-3151)
- [119-hr-9237: Take Care of America’s Veterans Act](https://policyrisk.com/legislation/119-hr-9237)
- [119-hr-2725: Affordable Housing Credit Improvement Act of 2025](https://policyrisk.com/legislation/119-hr-2725)
- [119-hr-3654: TERRA Act](https://policyrisk.com/legislation/119-hr-3654)
- [119-hr-137: TCJA Permanency Act](https://policyrisk.com/legislation/119-hr-137)
- [119-hr-6766: Essential Caregivers Act of 2025](https://policyrisk.com/legislation/119-hr-6766)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-9102 (as of 2026-10-04).